FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4284961436> ?p ?o ?g. }

• W4284961436 endingPage "e0270802" @default.
• W4284961436 startingPage "e0270802" @default.
• W4284961436 abstract "The basis of the antitumor immunotherapy, of which the purpose is the stimulation of the immune system. We have used two of the Pathogen Associated Molecular Patterns: unmethylated CpG oligonucleotide, a ligand of Toll-like receptor 9 (TLR9), and lipopolysaccharide (LPS) which is recognized by TLR4, combined with an agonistic OX40 receptor-specific monoclonal antibody (anti-OX40), which is expressed by activated regulatory T-cells (and by other activated T-cell populations as well). The objective of this study was to prove the effectiveness of the aforementioned compounds in an animal model, on a bladder cancer cell line.We have instilled MB49 cells subcutaneously, to the left musculus biceps femoris. We have created three observation groups, each containing ten mice. After eleven days, all treated mice bearing the size of 5-8 mm (in diameter) tumor were administered CpG + anti-OX40 or LPS + anti-OX40 three times with a three-day lap between each treatment. Mice in the control group did not receive any treatment.All the specimens from the control and LPS + anti-OX40 groups have died by the sixtieth day of the observation period, however, five mice from the CpG + anti-OX40 group were still alive. The experiment lasted until the last surviving mouse died, which occurred on the 357th day after tumor implantation.The treatment with LPS did not make anti-OX40 more potent and did not increase the survival times. However, CpG + anti-OX40 has shown increased antitumor activity compared to the other two groups." @default.
• W4284961436 created "2022-07-10" @default.
• W4284961436 creator A5041025522 @default.
• W4284961436 creator A5050779572 @default.
• W4284961436 creator A5060483520 @default.
• W4284961436 creator A5073454961 @default.
• W4284961436 creator A5075481172 @default.
• W4284961436 date "2022-07-08" @default.
• W4284961436 modified "2023-10-18" @default.
• W4284961436 title "Effects of the combination of a monoclonal agonistic mouse anti-OX40 antibody and toll-like receptor agonists: Unmethylated CpG and LPS on an MB49 bladder cancer cell line in a mouse model" @default.
• W4284961436 cites W1483682701 @default.
• W4284961436 cites W1576414450 @default.
• W4284961436 cites W1581119831 @default.
• W4284961436 cites W1978152737 @default.
• W4284961436 cites W1981073246 @default.
• W4284961436 cites W1987589866 @default.
• W4284961436 cites W2034394424 @default.
• W4284961436 cites W2047117683 @default.
• W4284961436 cites W2053433376 @default.
• W4284961436 cites W2055056105 @default.
• W4284961436 cites W2105357534 @default.
• W4284961436 cites W2109347785 @default.
• W4284961436 cites W2161625612 @default.
• W4284961436 cites W2162077796 @default.
• W4284961436 cites W2169035834 @default.
• W4284961436 cites W2189381691 @default.
• W4284961436 cites W2260107522 @default.
• W4284961436 cites W2302088846 @default.
• W4284961436 cites W2496085280 @default.
• W4284961436 cites W2747769029 @default.
• W4284961436 cites W278343460 @default.
• W4284961436 cites W2786472249 @default.
• W4284961436 cites W2973020268 @default.
• W4284961436 cites W4232939899 @default.
• W4284961436 doi "https://doi.org/10.1371/journal.pone.0270802" @default.
• W4284961436 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35802726" @default.
• W4284961436 hasPublicationYear "2022" @default.
• W4284961436 type Work @default.
• W4284961436 citedByCount "2" @default.
• W4284961436 countsByYear W42849614362023 @default.
• W4284961436 crossrefType "journal-article" @default.
• W4284961436 hasAuthorship W4284961436A5041025522 @default.
• W4284961436 hasAuthorship W4284961436A5050779572 @default.
• W4284961436 hasAuthorship W4284961436A5060483520 @default.
• W4284961436 hasAuthorship W4284961436A5073454961 @default.
• W4284961436 hasAuthorship W4284961436A5075481172 @default.
• W4284961436 hasBestOaLocation W42849614361 @default.
• W4284961436 hasConcept C104317684 @default.
• W4284961436 hasConcept C126322002 @default.
• W4284961436 hasConcept C140173407 @default.
• W4284961436 hasConcept C150194340 @default.
• W4284961436 hasConcept C153911025 @default.
• W4284961436 hasConcept C159654299 @default.
• W4284961436 hasConcept C170493617 @default.
• W4284961436 hasConcept C190727270 @default.
• W4284961436 hasConcept C203014093 @default.
• W4284961436 hasConcept C22801619 @default.
• W4284961436 hasConcept C2777701055 @default.
• W4284961436 hasConcept C2778754761 @default.
• W4284961436 hasConcept C2779138994 @default.
• W4284961436 hasConcept C502942594 @default.
• W4284961436 hasConcept C542903549 @default.
• W4284961436 hasConcept C55493867 @default.
• W4284961436 hasConcept C71924100 @default.
• W4284961436 hasConcept C86803240 @default.
• W4284961436 hasConcept C8891405 @default.
• W4284961436 hasConcept C98274493 @default.
• W4284961436 hasConceptScore W4284961436C104317684 @default.
• W4284961436 hasConceptScore W4284961436C126322002 @default.
• W4284961436 hasConceptScore W4284961436C140173407 @default.
• W4284961436 hasConceptScore W4284961436C150194340 @default.
• W4284961436 hasConceptScore W4284961436C153911025 @default.
• W4284961436 hasConceptScore W4284961436C159654299 @default.
• W4284961436 hasConceptScore W4284961436C170493617 @default.
• W4284961436 hasConceptScore W4284961436C190727270 @default.
• W4284961436 hasConceptScore W4284961436C203014093 @default.
• W4284961436 hasConceptScore W4284961436C22801619 @default.
• W4284961436 hasConceptScore W4284961436C2777701055 @default.
• W4284961436 hasConceptScore W4284961436C2778754761 @default.
• W4284961436 hasConceptScore W4284961436C2779138994 @default.
• W4284961436 hasConceptScore W4284961436C502942594 @default.
• W4284961436 hasConceptScore W4284961436C542903549 @default.
• W4284961436 hasConceptScore W4284961436C55493867 @default.
• W4284961436 hasConceptScore W4284961436C71924100 @default.
• W4284961436 hasConceptScore W4284961436C86803240 @default.
• W4284961436 hasConceptScore W4284961436C8891405 @default.
• W4284961436 hasConceptScore W4284961436C98274493 @default.
• W4284961436 hasFunder F4320338080 @default.
• W4284961436 hasIssue "7" @default.
• W4284961436 hasLocation W42849614361 @default.
• W4284961436 hasLocation W42849614362 @default.
• W4284961436 hasLocation W42849614363 @default.
• W4284961436 hasOpenAccess W4284961436 @default.
• W4284961436 hasPrimaryLocation W42849614361 @default.
• W4284961436 hasRelatedWork W105463312 @default.
• W4284961436 hasRelatedWork W2022441644 @default.
• W4284961436 hasRelatedWork W2092470514 @default.
• W4284961436 hasRelatedWork W2096956789 @default.

• next